Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
The Antioxidant Role of Hemp Phytocomplex in Cannabis Oil-Based ExtractsCamillo Morano, Michele Dei Cas, Gabriella Roda, et al.Molecules (Basel, Switzerland)|November 27, 2025
Redox Potential (E<sub>0</sub>') of the β-Chain 93Cys of HbS Measured with the Equilibrium Technique in a Heterozygous Sickle Cell Carrier SubjectFederico Maria Rubino, Aldijana Sadikovic, Camillo Morano, et al.Journal of Pharmaceutical and Biomedical Analysis|June 10, 2021
Characterization of chemotype-dependent terpenoids profile in cannabis by headspace gas-chromatography coupled to time-of-flight mass spectrometryMichele Dei Cas, Sebastiano Arnoldi, Laura Monguzzi, et al.Journal of Clinical Medicine|September 27, 2025
Evaluation of the Sphingolipidomic Profile in Women with Anorexia Nervosa: Relationships with Parameters Related to Body Composition, Cardiovascular Function, Glucometabolic Homeostasis, and Lipoprotein MetabolismAntonello E Rigamonti, Rita Paroni, Aldijana Sadikovic, et al.International Journal of Molecular Sciences|July 12, 2025
Hypoxic Status in COPD and ARDS Patients: Impact on Lipid SignatureCamillo Morano, Aldijana Sadikovic, Michele Dei Cas, et al.Planta Medica|November 14, 2023
Medicinal Cannabis: Extended Stability of Cannabis Extracts Produced Using a New Ethanol-based Extraction MethodCamillo Morano, Michele Dei Cas, Eleonora Casagni, et al.American Journal of Physiology. Endocrinology and Metabolism|August 28, 2024
Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population: CA.ME.LI.A study 7 years follow-upMonica Bignotto, Elena Bianco, Lucia Centofanti, et al.American Journal of Physiology. Endocrinology and Metabolism|March 24, 2026
The interaction between glucose levels and body mass index on the regulation of circulating sphingolipidome in humansCamillo Morano, Lucia Centofanti, Michele Dei Cas, et al.Pharmacological Research|December 31, 2025
Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and Type 2 Diabetes via 5-HT2B receptor-dependent mechanismsMartina Colognesi, Daniela Gabbia, Anna Signor, et al.Pageof 2